Novo Nordisk (NVO.N) released its 2026 sales and operating profit outlook, projecting adjusted sales growth of -5% to -13% (at constant exchange rates) for 2026.

2026-02-04

Novo Nordisk (NVO.N) released its 2026 sales and operating profit outlook, projecting adjusted sales growth of -5% to -13% (at constant exchange rates) for 2026.